Latest News in the pharma Industry

Policy & Regulation

FDA Approves Drug against Late-stage Head and Neck Cancer

FDA Approves Drug against Late-stage Head and Neck Cancer

8 Nov 2011

The FDA has approved Erbitux for use with chemotherapy to treat patients with late-stage head and neck cancer.

Read more 
FDA Accepts NDA Filing for Obesity Treatment

FDA Accepts NDA Filing for Obesity Treatment

7 Nov 2011

The FDA indicated that an advisory committee of the Division of Metabolism and Endocrinology Products (DMEP) will meet to discuss the Qnexa NDA in the first quarter of 2012.

Read more 
GSK Agrees to Settle US Drug Dispute for $3Bn

GSK Agrees to Settle US Drug Dispute for $3Bn

4 Nov 2011

GSK has agreed to pay $3bn to settle all US investigations into the way the company marketed and developed its products.

Read more 
India to Extend Price Control of Essential Medicines

India to Extend Price Control of Essential Medicines

4 Nov 2011

India is to extend its price control of essential medicines from the current 34 to at least 400 drugs.

Read more 
FDA Approves Felodipine Extended-release Tablets USP

FDA Approves Felodipine Extended-release Tablets USP

3 Nov 2011

FDA approves Endo Felodipine Extended-release Tablets USP, which are the generic version of AstraZeneca's Plendil Extended-release Tablets.

Read more 
Medicrime Convention Signed to Boost Cooperation against Pharmaceutical Crimes

Medicrime Convention Signed to Boost Cooperation against Pharmaceutical Crimes

1 Nov 2011

The Medicrime Convention is the first international treaty that obliges signatory states to criminalise the counterfeiting of medical products and similar crimes.

Read more 
NICE Approves AstraZeneca's Brilique

NICE Approves AstraZeneca's Brilique

31 Oct 2011

NICE approved the drug for use for up to 12 months as a treatment option for patients who have had a hear attack or an episode of unstable angina.

Read more 
EMA Simplifies SME Assignment Process

EMA Simplifies SME Assignment Process

31 Oct 2011

The new process is expected to reduce the administrative burden on companies and to speed up the SME assignment and renewal process.

Read more 
Atox Bio Granted Orphan Drug Designation for AB103

Atox Bio Granted Orphan Drug Designation for AB103

31 Oct 2011

The drug candidate has completed a Phase I study and expects to go into a Phase II proof-of-concept study to assess its clinical benefit.

Read more 
FDA Nods for Sagent Bupivacaine Hydrochloride Injection

FDA Nods for Sagent Bupivacaine Hydrochloride Injection

27 Oct 2011

Sagent Pharmaceuticals' bupivacaine hydrochloride injection wins FDA approval and will be available in six single-dose and two multi-dose latex-free vials.

Read more 
WHO Working Group to Hold Session against Counterfeit Medical Products

WHO Working Group to Hold Session against Counterfeit Medical Products

25 Oct 2011

The working group of the World Health Organisation will held its second meeting on the issue of spurious drugs from October 25 to 28 at Geneva.

Read more 
EU Antitrust Regulators Investigate Suspected Deal between J&J and Novartis

EU Antitrust Regulators Investigate Suspected Deal between J&J and Novartis

25 Oct 2011

EU regulators have launched investigation focused on a suspected agreement between Johnson & Johnson and Novartis to delay the sale of a generic painkiller in the Netherlands.

Read more